Monthly Archives: October 2017

Gene Editing: Where Should We Draw the Line?

October 25, 2017 · by · in Disability, Law & Policy, Science and Technology

Françoise Baylis continues to advocate for broad societal consensus on the future of germline genome editing and sees the Parliamentary Assembly of the Council of Europe as an ally given their support of broad public engagement.

The Politics of “Mixed-model” Home Care

October 20, 2017 · by · in Community, Disability, Law & Policy

Mary Jean Hande and Christine Kelly advocate for a publicly funded home care service that is guided by the best practices and the experiences of the people on the frontlines of care, namely health care workers, patients, and their families.

An Updated But Incomplete Picture: MAiD in Canada

October 12, 2017 · by · in Canadian Bioethics, Death & Assisted Dying, Law & Policy

Jocelyn Downie calls for more robust information about medical assistance in dying in Canada in order to help protect all vulnerable patients.

Psychedelics, Doing Science, and Policing History

October 10, 2017 · by · in Neuroethics, Pharmaceuticals, Science and Technology, Uncategorized

Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.

Canada’s Prohibition on Altering the Human Genome

October 2, 2017 · by · in Assisted Reproduction, Disability, Law & Policy, Science and Technology

Françoise Baylis and Alana Cattapan defend the current prohibition in Canada on making genetic alterations that can be passed on to future generations.